Atypical pharmacokinetics of atazanavir in an HIV-1-infected patient

Dario Cattaneo, Paola Meraviglia, Valeria Cozzi, Sara Baldelli, Greta Milani, Emilio Clementi

Research output: Contribution to journalArticlepeer-review


An HIV-infected patient with very low atazanavir (ATV) plasma trough concentrations despite clinical signs of poor drug tolerability was described. By therapeutic drug monitoring (TDM), the authors found that the patient had an atypical ATV pharmacokinetics characterized by rapid drug absorption followed by very fast drug clearance probably attributable to his genetic background. This case underlines the importance of traditional and pharmacogenetic-based TDM for the individualization of ATV therapy in HIV-1 patients.

Original languageEnglish
Pages (from-to)204-206
Number of pages3
JournalFundamental and Clinical Pharmacology
Issue number2
Publication statusPublished - Apr 2012


  • HIV
  • Pharmacogenetics
  • Pharmacokinetics
  • Therapeutic drug monitoring

ASJC Scopus subject areas

  • Pharmacology
  • Pharmacology (medical)


Dive into the research topics of 'Atypical pharmacokinetics of atazanavir in an HIV-1-infected patient'. Together they form a unique fingerprint.

Cite this